NCT05713903 Laparoscopic Versus Open Right Colectomy for Right Colon Cancer
| NCT ID | NCT05713903 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Larissa University Hospital |
| Condition | Colon Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 114 participants |
| Start Date | 2023-02-06 |
| Primary Completion | 2027-01-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 114 participants in total. It began in 2023-02-06 with a primary completion date of 2027-01-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research protocol is to compare open versus laparoscopic right colectomy (according to the CME technique of complete mesocolic excision) for right colon cancer. This study will be designed as a prospective randomized controlled trial. The comparison of the two techniques will include endpoints regarding the quality characteristics of the specimens and the oncological results. In addition, the effectiveness of the two methods will be evaluated in terms of the early and late postoperative period.
Eligibility Criteria
Inclusion Criteria: * Histologically confirmed right colon cancer (cecum, ascending colon, hepatic flexure) * Surgical resection based on the CME principles * Patient 18 to 90 years old * American Society of Anesthesiologists score ≤III * Τ≤3 * Elective operation * Signed informed consent of the patient Exclusion Criteria: * Non elective operation (hemorrhage, perforation, obstruction) * Locally advanced disease (T4) * Distant metastases (Stage IV) * American Society of Anesthesiologists ≥IV * Previous laparotomy * BMI \>35 kg/m2 * Active sepsis or systemic infection * Untreated physical and mental disability * Pregnancy or breast-feeding * Lack of compliance with the protocol process * Non-granting of signed informed consent
Contact & Investigator
Konstantinos Perivoliotis, MD
PRINCIPAL INVESTIGATOR
University Hospital of Larissa
Frequently Asked Questions
Who can join the NCT05713903 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Colon Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05713903 currently recruiting?
Yes, NCT05713903 is actively recruiting participants. Contact the research team at kperi19@gmail.com for enrollment information.
Where is the NCT05713903 trial being conducted?
This trial is being conducted at Larissa, Greece.
Who is sponsoring the NCT05713903 clinical trial?
NCT05713903 is sponsored by Larissa University Hospital. The principal investigator is Konstantinos Perivoliotis, MD at University Hospital of Larissa. The trial plans to enroll 114 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.